RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,286 | -54.7% | 15,080 | -45.9% | 0.00% | -50.0% |
| Q2 2023 | $35,965 | -68.2% | 27,880 | -67.5% | 0.00% | -71.4% |
| Q1 2023 | $113,124 | +281.9% | 85,700 | +333.9% | 0.01% | +250.0% |
| Q4 2022 | $29,625 | +18.5% | 19,750 | -5.7% | 0.00% | -20.0% |
| Q3 2022 | $25,000 | -65.3% | 20,945 | -33.5% | 0.01% | -66.7% |
| Q4 2018 | $72,000 | -36.3% | 31,500 | -10.5% | 0.02% | -16.7% |
| Q3 2018 | $113,000 | +94.8% | 35,200 | +120.9% | 0.02% | -52.6% |
| Q3 2016 | $58,000 | – | 15,934 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |